-
Src Related Products (225)
Related Products (225)
-
CpCDPK1/TgCDPK1-IN-1
0 ImagesCat. No.: HY-128397CAS No.: 1092788-23-2CpCDPK1/TgCDPK1-IN-1 (compound 7p) is a potent CpCDPK1/TgCDPK1 dual inhibitor (IC50: 10 nM and 5.0 nM respectively). CpCDPK1/TgCDPK1-IN-1 also inhibits Abl and Src (IC50: 75 nM and 65 nM respectively). CpCDPK1/TgCDPK1-IN-1 can be used for research of toxoplasmosis.
-
HPK1-IN-2 TFA
0 ImagesCat. No.: HY-132150CPurity: 99.56%
-
Lysoganglioside-GM1 potassium
0 ImagesCat. No.: HY-131931CAS No.: 171483-40-2Synonyms: LysoGM1 potassiumLysoganglioside-GM1 (LysoGM1) potassium is a derivative of Monosialoganglioside GM1, which lacks a fatty acid. Lysoganglioside-GM1 potassium is also an inhibitor of GM1 aggregation. Lysoganglioside-GM1 potassium can inhibit the activation of Lyn and laminin-1-mediated neurite outgrowth. Lysoganglioside-GM1 potassium can be used in the research of nervous system diseases.
-
Bosutinib hydrate (Standard)
0 ImagesSynonyms: SKI-606 hydrate (Standard)Bosutinib (Standard) (SKI-606 (Standard)) hydrate is the analytical standard of Bosutinib hydrate (HY-10158A). This product is intended for research and analytical applications. Bosutinib hydrate is an oraly activel Src/Abl tyrosine kinase inhibito with IC50s of 1.2 nM and 1 nM, respectively.
-
DC-Srci-6649
0 ImagesCat. No.: HY-139890CAS No.: 1037545-61-1DC-Srci-6649 is a c-Src kinase inhibitor that inhibits the phosphorylation and locks c-Src in the inactive state.
-
SRC-3-IN-1
0 ImagesCat. No.: HY-163468CAS No.: 2137490-93-6SRC-3-IN-1 (compound SI-10) is a steroid receptor coactivator 3 (SRC-3) inhibitor (IC50=3.3 μM). SRC-3-IN-1 has good water solubility, oral bioavailability, and improved selectivity profile. SRC-3-IN-1 can be used in prostate cancer research.
-
LCB 03-0110 dihydrochloride
0 ImagesCat. No.: HY-110367CAS No.: 1962928-28-4LCB 03-0110 dihydrochloride is a dihydrochloride of LCB 03-0110. LCB 03-0110 is a potent inhibitor of Src family tyrosine kinase.
-
Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH
0 ImagesCat. No.: HY-P1200CAS No.: 159439-02-8
-
Lck-IN-4
0 ImagesCat. No.: HY-178120CAS No.: 1326278-38-9Lck-IN-4 (Compound A-1) is a protein tyrosine kinase Lck inhibitor with an IC50 of 2 nM. Lck-IN-4 significantly inhibits YAP tyrosine phosphorylation and activity and induces apoptosis in cholangiocarcinoma CCA cells. Lck-IN-4 is cytotoxic in CCA tumor-derived organoids with elevated YAP activity Lck-IN-4 can be used for cancers like cholangiocarcinoma (CCA) research.
-
AD57 hydrochloride
0 ImagesCat. No.: HY-18507ACAS No.: 2320261-72-9
-
Antiproliferative agent-54
0 ImagesCat. No.: HY-135216CAS No.: 1240322-54-6Antiproliferative agent-54 (Compound 6z) is the inhibitor for multiple kinases, such as ABL WT, B-RAF, EGFR, HCK, LYN A and SRC with IC50 of 6-50 nM. Antiproliferative agent-54 inhibits proliferation of several cancer cell, inhibits HUVEC and HepG2, with EC50 of 34 and 38 nM. Antiproliferative agent-54 exhibits good pharmacokinetic characteristics in rats.
-
Scr-IN-2
0 ImagesCat. No.: HY-175845CAS No.: 2787582-78-7
-
FAK inhibitor 7
0 ImagesCat. No.: HY-162879CAS No.: 2890814-94-3FAK inhibitor 7 is a type of FAK inhibitor with an IC50 value of 3.58 nM. FAK inhibitor 7 can inhibit the downstream signaling cascades of FAK (like Src and AKT), causing ovarian cancer cells to stall in the G0/G1 phase and induce cytotoxic autophagy. FAK inhibitor 7 can also suppress tumor metastasis and growth in ovarian cancer mice.
-
Squarunkin A hydrochloride
0 ImagesCat. No.: HY-127002ACAS No.: 2253744-55-5
-
AP-22161
0 ImagesCat. No.: HY-123394CAS No.: 268741-42-0AP22161 is a potent and selective Src SH2 domain inhibitor with an IC50 of 0.24 µM. AP22161 exhibits >120-fold selectivity over Yes SH2 (IC50 = 29.38 µM) and ZAP SH2 (IC50 = 421.86 µM). AP22161 inhibits Src-dependent cellular activity and diminishes osteoclast resorptive activity. AP22161 can be used for osteoporosis research.
